In a report released on January 23, Chris Cooper from Goldman Sachs maintained a Hold rating on Pro Medicus Limited (PMCUF – Research Report), with a price target of A$51.60. The company’s shares closed last Monday at $44.51.
According to TipRanks, Cooper is a 2-star analyst with an average return of 1.5% and a 52.00% success rate.
The word on The Street in general, suggests a Hold analyst consensus rating for Pro Medicus Limited with a $41.52 average price target.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $44.51 and a one-year low of $25.74. Currently, Pro Medicus Limited has an average volume of 622.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Pro Medicus Ltd is a health imaging IT provider. The company provides a comprehensive range of health imaging software and services to hospitals, imaging centres and health care groups worldwide. The product line comprises solutions for RIS (Radiology Information Systems) /Practice Management, Healthcare Imaging, and e-health. Pro Medicus also offers software applications for medical accounting, clinical reporting, appointments/scheduling and marketing/management. The business is spread across North America, Australia, and Europe.
Read More on PMCUF:
